Spotlight On: Advanced Gynecologic Ultrasound and Imaging

This month, we cast a spotlight on articles, SurgeryU videos, and Journal of Minimally Invasive Gynecology (JMIG) article recommendations from the AAGL Advanced Gynecologic Ultrasound and Imaging (SIG) led by Chair Mathew Leonardi, MD, PhD, FRCSC.
Access to SurgeryU and JMIG are two of the many benefits included in AAGL membership. The SurgeryU library features high-definition surgical videos by experts from around the world. JMIG presents cutting-edge, peer-reviewed research, clinical opinions, and case report articles by the brightest minds in gynecologic surgery.
SurgeryU video and JMIG article recommendations by our SIGs are accessible by AAGL members only. For full access to SurgeryU, JMIG, CME programming, and member-only discounts on meetings, join AAGL today!
Closing an Imaging Gap: Non-Invasive Imaging-Based Diagnosis of Superficial Endometriosis
For nearly a decade, the International Deep Endometriosis Analysis (IDEA) group’s consensus opinion provided guidance regarding ultrasound detection of deep endometriosis. Superficial peritoneal disease has remained largely invisible to imaging, yet it is found in roughly 80% of women with endometriosis. Many of these patients have a “normal” scan and would require laparoscopy for diagnosis. Fortunately, that is beginning to change. The role of ultrasound in detecting superficial endometriosis has been increasingly studied in recent years, alongside advances in technology and technique. In July 2025, an 18-member IDEA panel of sonologists and advanced laparoscopic surgeons published the first standardized ultrasound protocol for detecting superficial endometriosis.
The protocol focuses on where disease is most common and easiest to see: the posterior cul-de-sac. Free peritoneal fluid serves as the acoustic window. Many women have a small amount of physiologic fluid throughout the natural cycle, though hormonal therapy can reduce it. When fluid is lacking, sonoPODography can create a window; saline is instilled through an intrauterine balloon catheter, as in tubal patency testing, and spills through the tubes into the cul-de-sac.
The panel found indirect signs, or “soft markers,” to be of limited value. Drawing on work by Pedrassani et al and Leonardi et al, it agreed on five direct signs, each corresponding to a laparoscopic appearance:
- Hypoechoic tissue, reflecting stromal reaction or fibrosis
- Hyperechoic foci within cysts, reflecting hemosiderin deposits
- Small or large peritoneal pocket(s), associated with vesicles
- Solitary cyst (vesicle), associated with the presence of clear or red vesicles
- Clustered cysts, corresponding to multiple clear or red vesicles
Lesions typically measure only 1–5 mm. Figures 3 and 4 of the publication offer image examples.
The diagnostic delay in endometriosis begins in adolescence. Where a standard transvaginal probe is not tolerated or should not be utilized, smaller-caliber transvaginal or transrectal probes can be used to assess for superficial endometriotic lesions. Further development of small endocavitary probes would widen access for young patients.
Infertility offers a second opportunity. Saline-based tubal patency testing already introduces fluid into the cul-de-sac. A protocolized cul-de-sac survey immediately afterward could flag superficial disease in women with otherwise unexplained infertility. Anechoic saline is preferable, since echogenic foam may obscure millimeter lesions.
This article’s message for our field is clear: an ultrasound scan without evidence of deep or ovarian disease is not the end of the evaluation. For patients with pain or infertility, routine imaging should now include a dedicated assessment of the peritoneum.

Figure 3: Summary of ultrasonographic findings associated with the presence of superficial endometriosis. Findings may appear in isolation (a,b,c) or in combination (d), and different lesions may show different associated findings within the same patient.

Figure 4: Examples of the ultrasound appearance of superficial endometriosis: (a) clustered linear cysts (arrows) with a hyperechogenic focus; (b) clustered tiny cyst (yellow circle and arrow) and two solitary cysts (arrows); (c) clustered tiny cysts with a honeycomb appearance; (d) solitary cyst (vesicle) (arrow); (e) clustered tiny cysts with a linear appearance (yellow circle and arrows), solitary tiny cyst (red circle and arrow) and solitary tiny cyst in a peritoneal small pocket (blue circle and arrow); (f) clustered tiny cysts with a honeycomb appearance (yellow circle and arrows) and solitary tiny cyst (red circle and arrow); (g) clustered tiny cysts with a hypoechogenic associated lesion (yellow circle and arrow), solitary cyst with a hyperechogenic focus in a small peritoneal pocket (red circle and arrow) and clustered cysts with a honeycomb appearance (blue circle and arrow); (h) solitary tiny cyst with hypoechogenic associated lesion and hyperechogenic focus (yellow circle and arrow) and clustered tiny cysts (red circle and arrow); (i) clustered cysts with a honeycomb appearance (arrows). POD, pouch of Douglas.
References:
- Guerriero, S., Condous, G., Rolla, M., Pedrassani, M., Leonardi, et al . (2025), Addendum to consensus opinion from the International Deep Endometriosis Analysis (IDEA) group: sonographic evaluation of superficial endometriosis. Ultrasound Obstet Gynecol, 66: 541-547. https://doi.org/10.1002/uog.29288.
- Guerriero, S., Condous, G., van den Bosch, T. et al . (2016), Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol, 48: 318-332. https://doi.org/10.1002/uog.15955.
- Condous G, Gerges B, Thomassin-Naggara I, Becker C, Tomassetti C, Krentel H, van Herendael BJ, Malzoni M, Abrao MS, Saridogan E, Keckstein J, Hudelist G; Collaborators. Non-invasive imaging techniques for diagnosis of pelvic deep endometriosis and endometriosis classification systems: an International Consensus Statement. Ultrasound Obstet Gynecol. 2024 Jul;64(1):129-144. doi: 10.1002/uog.27560. Epub 2024 May 29. PMID: 38808587.
- International working group of AAGL, ESGE, ESHRE and WES; Tomassetti C, Johnson NP, Petrozza J, Abrao MS, Einarsson JI, Horne AW, Lee TTM, Missmer S, Vermeulen N, Zondervan KT, Grimbizis G, De Wilde RL. An International Terminology for Endometriosis, 2021. J Minim Invasive Gynecol. 2021 Nov;28(11):1849-1859. doi: 10.1016/j.jmig.2021.08.032. Epub 2021 Oct 21. PMID: 34690084.
- Leonardi M, Robledo KP, Espada M, Vanza K, Condous G. SonoPODography: A new diagnostic technique for visualizing superficial endometriosis. Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:124-131. doi: 10.1016/j.ejogrb.2020.08.051. Epub 2020 Sep 16. PMID: 32961428.
- Pedrassani M, Guerriero S, Pascual MÁ, Ajossa S, Graupera B, Pagliuca M, Podgaec S, Camargos E, Vieira de Oliveira Y, Alcázar JL. Superficial Endometriosis at Ultrasound Examination-A Diagnostic Criteria Proposal. Diagnostics (Basel). 2023 May 27;13(11):1876. doi: 10.3390/diagnostics13111876. PMID: 37296728; PMCID: PMC10252330.
Author:
Sophia N. Palmer, MD, FACOG

SIG Recommended SurgeryU Video #1:
A Step-By-Step Approach to Uterosacral Ligaments Evaluation on Transvaginal Ultrasound
By Melissa Marien, Geoffrey Zeni, Ido Mick, Jayesh Tigdi, Sarah Scottolon, Mathew Leonardi
The uterosacral ligaments are the most frequently involved site of deep endometriosis, yet they remain among the hardest structures to assess on ultrasound. In this video, Marien and colleagues demonstrate a stepwise transvaginal approach to finding and evaluating the uterosacral ligaments. They illustrate it with images and cineclips from patients seen in their practice. The authors conclude that transvaginal ultrasound is a valuable tool for mapping endometriosis, both for diagnosis and for surgical planning. This video is a practical resource for anyone building a systematic endometriosis scan and it is a great teaching tool for trainees.
SIG Recommended SurgeryU Video #2:
The “Triangle Sign”: A Novel Dynamic Ultrasound Technique for Identifying an Obliterated Cul-De-Sac in Patients with a Retroverted Uterus
By Ido Mick, Melissa Marien, Jayesh Tigdi, Geoffrey Zeni, Sarah Scattolon, Mathew Leonardi
The sliding sign is a dynamic ultrasound technique for detecting cul-de-sac obliteration. When the uterus is retroverted, this test can be more challenging to perform and interpret. In this video, the authors demonstrate the “triangle sign,” a maneuver designed to supplement the sliding sign in these patients. Pressure is released from the vaginal probe and fluid in the posterior cul-de-sac creates a triangular shape between the posterior uterus, cul-de-sac and rectum. This sign makes preoperative ultrasound triage more reliable when the uterus is retroverted.
Video Recommendations By:
Sophia N. Palmer, MD, FACOG

JMIG Article Recommendation #1:
Non-Invasive Imaging Techniques for Diagnosis of Pelvic Deep Endometriosis and Endometriosis Classification Systems: An International Consensus Statement
George Condous, MD, Bassem Gerges, Isabelle Thomassin-Naggara, MD, PhD, Christian M. Becker, MD, Carla Tomassetti, MD, Harald Krentel, MD, Bruno J. van Herendael, MD, Mario Malzoni, MD, Mauricio S. Abrao, MD, PhD, Ertan Saridogan, MD, PhD, MRCOG, Joerg Keckstein, MD, Gernot Hudelist, MD
This international multidisciplinary consensus statement establishes recommendations for using transvaginal ultrasound and MRI to diagnose and map pelvic deep endometriosis. It emphasizes systematic assessment of disease location, standardized terminology, and the role of imaging in applying endometriosis classification systems. The authors support expert transvaginal ultrasound as a first-line imaging modality, with MRI providing complementary information in selected circumstances.
JMIG Article Recommendation #2:
Ultrasound Evaluation of Retrocervical and Parametrial Deep Endometriosis on the Basis of Surgical Anatomic Landmarks
Alessandra Di Giovanni, MD, Lucia Casarella, MD, Marina Coppola, MD, Francesca Falcone, MD, Domenico Iuzzolino, MD, Marianna Rasile, MD, Mario Malzoni, MD
This study describes a systematic transvaginal ultrasound approach to evaluating retrocervical and parametrial deep endometriosis using anatomical landmarks relevant to surgery. It emphasizes differentiation of disease involving the uterosacral ligaments, torus uterinus, and parametrial structures, where precise localization can affect surgical planning. The article demonstrates the importance of detailed compartmental mapping rather than simply reporting the presence of posterior pelvic endometriosis.
JMIG Article Recommendations By:
Scott W. Young, MD, FSRU

Listening Beyond the Amenorrhea
A patient was referred to our one-stop minimally invasive gynecology and ultrasound clinic to be considered for surgery. She had persistent pelvic pain despite amenorrhea on medical management. She had previously undergone surgical treatment with ablation, and multiple combined oral contraceptive pills had failed to control her symptoms. Trials of GnRH agonists (leuprolide acetate and goserelin acetate) with add-back provided the symptom relief she wanted, which suggested a hormonally driven component to her pain. They were stopped because of reduced bone density.
Before referral, she was started on drospirenone 4 mg daily, a progestin-only pill whose main mechanism of action is suppressing ovulation. A 52 mg levonorgestrel intrauterine device was also placed. She achieved amenorrhea, and her menstrual associated dysmenorrhea resolved completely. However, she continued to have predictable cyclic pelvic pain, overlapping with chronic left-sided pelvic pain.
After a complete history and physical examination, we performed a point-of-care ultrasound. The examination showed global pelvic floor dysfunction and diffuse tenderness. This myofascial dysfunction was a plausible explanation for her noncyclic daily pelvic pain. Ultrasound showed an anteverted uterus with a correctly positioned intrauterine device and a 22.3 mm dominant follicle in the left ovary (Figure 1). Superficial endometriosis was seen centrally on the rectouterine pouch peritoneum (Figure 2). The dominant follicle suggested ongoing follicular activity, so we drew a serum estradiol level. It measured 214 pmol/L (approximately 58 pg/mL), which is above Barbieri’s proposed therapeutic range of 30 to 45 pg/mL (approximately 110 to 165 pmol/L).

Figure 1: Transvaginal ultrasound of the left ovary demonstrating a dominant follicle.

Figure 2: Transvaginal ultrasound image demonstrating superficial endometriosis in the rectouterine pouch (white arrow).
Taken together, the cyclic pain pattern, dominant follicle, and estradiol level supported persistent ovarian activity despite amenorrhea. This suggested she was not adequately suppressed on her current drospirenone dose. After shared decision-making, the patient chose an off-label trial of drospirenone 8 mg daily, with a plan to reassess her symptoms and ovarian activity. We repeated the estradiol after exactly one month, ideally within the same folliculogenesis window as the first assessment. It had dropped from 214 to 87 pmol/L. At a telephone follow-up, she reported improvement in the cyclic pelvic pain she had described before.
We will keep monitoring her symptoms, and we have added pelvic floor physiotherapy. We are optimistic that this comprehensive diagnostic approach and individualized management plan will be effective. This case may seem obvious or “common sense.” Yet we see countless cases of “failed medical therapy” where, in reality, the medication is not having its intended pharmacodynamic effect. Sometimes the most obvious issues are right in front of us, and we still have difficulty seeing them. Here, we tracked symptoms carefully alongside ultrasound findings and bloodwork, and that let us adjust her medication to reach the intended goal: suppressing ovarian estrogen production. Amenorrhea and anovulation may overlap, but they are not the same thing. If readers take away one question, it is this: even though amenorrhea has been achieved, has the treatment controlled the other physiologic events that generate symptoms? If not, can it be adjusted to work better?
About the Author:
Nora Mohamed, MBBS
Mathew Leonardi, MD, PhD, FRCSC

Dr. Mohamed is a Clinical Fellow in the Advanced Gynecologic Ultrasound Department of Obstetrics and Gynecology at McMaster University in Hamilton, Ontario, Canada

Dr. Leonardi is a Gynecologic Surgeon Sonologist at Hamilton Health Sciences and Associate Professor at McMaster University in Hamilton, Ontario, Canada.

Ovarian Endometrioma Sclerotherapy: An Ovary-Sparing Alternative
Ovarian endometriomas are common in endometriosis, with prevalence ranging from 10% in subfertile populations to more than 40% in selected clinical cohorts. They frequently coexist with deep endometriosis, increasing management complexity. [1,2,3]
Their relationship with fertility is complex: endometriomas are associated with reduced ovarian reserve, while non-ovarian endometriosis and coexisting pelvic diseases, such as adenomyosis, may independently affect reproductive outcomes. [4,5]
When intervention is indicated, surgery can treat endometriomas and associated pelvic disease, but cystectomy may remove healthy ovarian cortex and further compromise ovarian reserve, particularly in patients with bilateral or recurrent disease or diminished reserve. [4,5,6,7]
Management is individualized according to symptoms, disease characteristics, fertility goals, and ovarian reserve, and may include expectant, medical, or interventional treatment. Interventions include drainage, ablation, cystectomy, and sclerotherapy. [4,5,8]
Sclerotherapy is a minimally invasive, ovary-sparing treatment for ovarian endometriomas. It can be performed transvaginally or percutaneous under ultrasound guidance, or laparoscopically. A sclerosing agent, usually 95–96% ethanol, ablates the cyst lining while preserving the ovarian cortex. [9,10,11,12]
The rationale is simple: sclerotherapy may salvage more ovarian cortex than cystectomy. The endometrioma wall and ovarian cortex often lacks a clear cleavage plane, complicating ovarian tissue preservation, with tissue loss potentially increasing with cyst size. Cystectomy is associated with reduced serum AMH, while repeat surgery for recurrent endometrioma may further compromise ovarian reserve. [6,7]
In the ultrasound-guided approach, real-time imaging allows a safe transvaginal trajectory while avoiding bowel, bladder, and vessels. The cyst is aspirated, followed by saline lavage, and ethanol is instilled and retained before removal (Figure 1). Protocols vary, but pooled data suggest that retaining ethanol for more than 10 minutes is associated with lower recurrence (11.2% vs. 20.9%). [9]

Figure 1: This image illustrates aspiration of the endometrioma under real-time ultrasound guidance, allowing a safe needle trajectory while avoiding the bowel, bladder, and blood vessels. The cyst undergoes aspiration of its contents, followed by saline lavage, ethanol instillation and retention, and subsequent removal of the ethanol.
An updated meta-analysis of 28 studies (1,301 patients) reported 98.3% technical efficacy, 85.9% pain resolution, 13.8% recurrence, 37.6% pregnancy, and 1.7% major complications. Compared with cystectomy, sclerotherapy yielded 2.7 more oocytes on average, with similar clinical pregnancy rates. [9]
However, sclerotherapy is not appropriate for every endometrioma. No histologic diagnosis is obtained, making confident pre-procedure sonographic diagnosis essential. Diagnostic uncertainty, suspicion of malignancy, or a non-classical lesion should preclude treatment. Using the International Ovarian Tumour Analysis (IOTA)
group work, endometriomas can be identified as a typical unilocular cystic lesion with ground glass (low level echogenic) contents and without solid components or abnormal Doppler vascularity (Figure 2). Sclerotherapy may be unsuitable when deep endometriosis requires surgery or transvaginal access is unsafe. [9,12]

Figure 2: This image demonstrates a typical endometrioma by the IOTA group work criteria. The cyst is unilocular with ground glass contents (low level echogenic), without solid components or abnormal Doppler vascularity.
Sclerotherapy carries risks, including severe pain from ethanol and chemical peritonitis from leakage. Comprehensive sonographic mapping of deep endometriosis and adhesions may improve outcomes, while targeting the primary adhesion site may reduce leakage (Figure 3). Prophylactic pelvic saline infusion via sonohysterography may be considered to dilute ethanol (Figure 4). Other reported complications include infection, abscess, recurrence, and incomplete aspiration of multilocular lesions. [9,11,12]

Figure 3: This image demonstrates ultrasound-guided needle aspiration of the endometrioma contents following sonographic mapping of deep endometriosis lesions and adhesions.
Figure 4: The video demonstrates sonohysterography with the instillation of normal saline into the uterine cavity, allowing its distribution throughout the pelvic cavity. This technique aims to dilute the ethanol in the event of leakage, thereby reducing the risk of chemical peritonitis.
In summary, sclerotherapy offers a minimally invasive, ovary-sparing treatment option for ovarian endometriomas with relatively low recurrence rates. Its key limitation is the lack of histologic diagnosis, making accurate pre-procedure imaging essential. For selected patients, particularly those prioritizing fertility preservation, it is a valuable therapeutic option.
References:
1. Chaggar P, Tellum T, Thanatsis N, De Braud LV, Setty T, Jurkovic D. Prevalence of deep and ovarian endometriosis in women attending a general gynecology clinic: prospective cohort study. Ultrasound Obstet Gynecol. 2023;61(5):632-641. doi:10.1002/uog.26175.
2. Alson S, Jokubkiene L, Henic E, Sladkevicius P. Prevalence of endometrioma and deep infiltrating endometriosis at transvaginal ultrasound examination of subfertile women undergoing assisted reproductive treatment. Fertil Steril. 2022;118(5):915-923. doi:10.1016/j.fertnstert.2022.07.024.
3. Freger SM, Marien M, Mick I, Leonardi M. Anatomical distribution of ovarian and deep endometriosis using a multimodal diagnostic approach applying the updated international definition: a prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2026;318:114947. doi:10.1016/j.ejogrb.2026.114947.
4. Supramaniam PR, Mittal M, Becker C, Jayaprakasan K; Royal College of Obstetricians and Gynaecologists. The effect of surgery on endometriomas on fertility (2025 second edition): Scientific Impact Paper No. 55. BJOG. 2025;132(11):e175-e184. doi:10.1111/1471-0528.18221.
5. Elizur SE, Mostafa J, Berkowitz E, Orvieto R. Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes. Arch Gynecol Obstet. 2025;312(4):1037-1048. doi:10.1007/s00404-025-08124-1.
6. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531-1538. doi:10.1016/j.fertnstert.2012.08.009.
7. Muzii L, Achilli C, Lecce F, Bianchi A, Franceschetti S, Marchetti C, et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril. 2015;103(3):738-743. doi:10.1016/j.fertnstert.2014.12.101.
8. Kalra R, McDonnell R, Stewart F, Hart RJ, Hickey M, Farquhar C. Excisional surgery versus ablative surgery for ovarian endometrioma. Cochrane Database Syst Rev. 2024;11(11):CD004992. doi:10.1002/14651858.CD004992.pub4.
9. Kim GH, Kim PH, Shin JH, Nam IC, Chu HH, Ko HK. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. Eur Radiol. 2022;32(3):1726-1737. doi:10.1007/s00330-021-08270-5.
10. Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117-124.e5. doi:10.1016/j.fertnstert.2017.05.015.
11. Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Mañalich L, Gomez M, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133-1140.e5. doi:10.1016/j.jmig.2019.08.036.
12. Han K, Seo SK, Kim MD, Kim GM, Kwon JH, Kim HJ, et al. Catheter-directed sclerotherapy for ovarian endometrioma: short-term outcomes. Radiology. 2018;289(3):854-859. doi:10.1148/radiol.2018180606.
Authors:
Dr. Maayan Gal Kochav, MD
Dr. Mathew Leonardi, MD, PhD, FRCSC


Dr. Leonardi is a Gynecologic Surgeon Sonologist at Hamilton Health Sciences and Associate Professor at McMaster University in Hamilton, Ontario, Canada.









